Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miron Sopic

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Molecular Therapy. Nucleic Acids|March 5, 2024
Exploring pulmoprotection in COVID-19: Moving toward microRNA-based theranosticsMiron Sopic
European Heart Journal|January 8, 2024
Leveraging epitranscriptomics for cardiovascular disease theranosticsMiron Sopic, Victoria Stopa, Yvan Devaux
Vascular Pharmacology|May 9, 2025
Single-cell RNA sequencing (scRNA-seq) and its insights into cellular heterogeneity in atherosclerosisBaixue Yu, Miron Sopic, Judith C Sluimer
European Heart Journal|April 12, 2023
Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease researchMiron Sopic, Georgios Kararigas, Yvan Devaux, et al.
Pharmacological Reviews|October 30, 2025
Harnessing multiomics technologies and machine learning for advancing personalized theranostic approaches in atherosclerosisSoumaya Ben-Aicha, Prashant Srivastava, Georgios Kararigas, et al.
Vascular Pharmacology|April 16, 2025
Epitranscriptomics in atherosclerosis: Unraveling RNA modifications, editing and splicing and their implications in vascular diseaseVictoria Stopa, Dimitra Dafou, Korina Karagianni, et al.
Seminars in Cancer Biology|June 10, 2025
The converging roles of microRNAs and lipid metabolism in atherosclerotic cardiovascular disease and cancerSandra Vladimirov, Marija Tomasevic, Nemanja Popov, et al.
Biochemia Medica|June 26, 2015
Circulating resistin protein and mRNA concentrations and clinical severity of coronary artery diseaseJelena Joksic, Miron Sopic, Vesna Spasojevic-Kalimanovska, et al.
Critical Care (London, England)|February 26, 2026
Blood N1-methyladenosine (m<sup>1</sup>A) RNA modification and outcome after cardiac arrestVictoria Stopa, Miron Sopic, François Bernardin, et al.
Molecular Biology Reports|August 27, 2024
COVID-19 increases mortality in hemodialysis patients: exploring links with inflammation and telomere attritionTamara Milosevic, Radomir Naumovic, Miron Sopic, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Molecular Therapy. Nucleic Acids|March 5, 2024
Exploring pulmoprotection in COVID-19: Moving toward microRNA-based theranosticsMiron Sopic
European Heart Journal|January 8, 2024
Leveraging epitranscriptomics for cardiovascular disease theranosticsMiron Sopic, Victoria Stopa, Yvan Devaux
Vascular Pharmacology|May 9, 2025
Single-cell RNA sequencing (scRNA-seq) and its insights into cellular heterogeneity in atherosclerosisBaixue Yu, Miron Sopic, Judith C Sluimer
European Heart Journal|April 12, 2023
Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease researchMiron Sopic, Georgios Kararigas, Yvan Devaux, et al.
Pharmacological Reviews|October 30, 2025
Harnessing multiomics technologies and machine learning for advancing personalized theranostic approaches in atherosclerosisSoumaya Ben-Aicha, Prashant Srivastava, Georgios Kararigas, et al.
Vascular Pharmacology|April 16, 2025
Epitranscriptomics in atherosclerosis: Unraveling RNA modifications, editing and splicing and their implications in vascular diseaseVictoria Stopa, Dimitra Dafou, Korina Karagianni, et al.
Seminars in Cancer Biology|June 10, 2025
The converging roles of microRNAs and lipid metabolism in atherosclerotic cardiovascular disease and cancerSandra Vladimirov, Marija Tomasevic, Nemanja Popov, et al.
Biochemia Medica|June 26, 2015
Circulating resistin protein and mRNA concentrations and clinical severity of coronary artery diseaseJelena Joksic, Miron Sopic, Vesna Spasojevic-Kalimanovska, et al.
Critical Care (London, England)|February 26, 2026
Blood N1-methyladenosine (m<sup>1</sup>A) RNA modification and outcome after cardiac arrestVictoria Stopa, Miron Sopic, François Bernardin, et al.
Molecular Biology Reports|August 27, 2024
COVID-19 increases mortality in hemodialysis patients: exploring links with inflammation and telomere attritionTamara Milosevic, Radomir Naumovic, Miron Sopic, et al.
Pageof 3